NRP1 and glioblastoma: To test, we performed single-cell RNA sequencing (scRNA-Seq) using 3 patient-derived GBM tumors and classified these cells based on the expression levels of NRP1 mRNA, stemness, and TGF-β signaling gene signatures (32–36).